Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review.
Radha Korupolu, Aila Malik, Chelsea Ratcliff and 2 others
PMID 35760105WHAT IT FOUND
In MS, brain injury, spinal cord injury and ALS, 85% of people who started a mindfulness programme finished it, and satisfaction averaged 4.6 out of 5.
Depression, anxiety and fatigue fell, but far less when the comparison group got another active treatment.
Key findings
01Mindfulness-based programmes were workable for these patients: across 40 studies, an average of 85% of those who started completed the programme and the assessment straight afterwards, and satisfaction averaged 4.6 out of 5.
02Depression symptoms fell by a median 27% relative to controls after the programme, but the drop was 43% against people receiving no extra treatment and only 14% against those given another active treatment.
03Anxiety and fatigue followed the same pattern: median reductions of 23% and 19% overall, but only 10% and 11% when the comparison group received another active treatment.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only studies published in English from 2001 onwards were included, and no unpublished or non-peer-reviewed work, so relevant work in other languages or from earlier years is missing. Very few studies were in people with spinal cord injury (1 study) or ALS (2 studies), so the findings may not carry over to those groups. Among the trials used for the outcome analyses, 19% of the depression and anxiety studies, 29% of the fatigue studies and 10% of the quality-of-life studies were rated high risk of bias, and the authors say this should make readers cautious about those results. The outcome figures are medians of a relative change calculation across studies using different questionnaires, not pooled effect sizes, so the size of any benefit is approximate and should not be read as a precise treatment effect. Most comparisons were against usual care or a waiting list rather than another active treatment, which tends to make any active intervention look better. Fewer than half of the studies (19 of 44) measured anything after the programme ended, and only four followed people out to 12 months. Only 9 of the 32 studies that recommended home practice reported whether participants did it, so how much home practice people actually manage is uncertain. Acceptability data came from only 8 studies, which the authors say is too few to compare in-person with online delivery or live with self-paced delivery.
The easy way to misread this
Do not read the percentage reductions as proof that mindfulness beats other active treatments. The 27% figure for depression is a median of relative changes across studies that used different questionnaires, not a pooled effect size, and against people who received another active treatment such as exercise or psychoeducation the reduction was 14%. The authors also note that 19% of the trials in the depression and anxiety analysis and 29% of those in the fatigue analysis were rated high risk of bias.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →